Inclusion of premenopausal women in breast cancer clinical trials

BACKGROUND: Patients with premenopausal breast cancer (PMBC) have been historically excluded from some clinical trials because of the limitations of using endocrine therapy (ET) in this population. We analyzed breast cancer randomized clinical trials (RCTs) to determine the rates of and factors asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrigan, Kelsey L., Kouzy, Ramez, Jaoude, Joseph Abi, Patel, Roshal R., Layman, Rachel M., Giordano, Sharon H., Woodward, Wendy A., Smith, Benjamin D., Shaitelman, Simona F., Ludmir, Ethan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637813/
https://www.ncbi.nlm.nih.gov/pubmed/36327626
http://dx.doi.org/10.1016/j.breast.2022.10.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637813/
https://www.ncbi.nlm.nih.gov/pubmed/36327626
http://dx.doi.org/10.1016/j.breast.2022.10.013

Ejemplares similares